Dr. Pereira has been a member of the ProKidney Board since January 2022. Dr. Pereira has served as the Chief Executive Officer at Visterra Inc., a clinical-stage biotechnology company committed to developing innovative antibody-based therapies for the treatment of patients with kidney diseases and other hard-to-treat diseases and a subsidiary of Otsuka America Inc., a global healthcare company listed on Tokyo Stock Exchange, since July 2013. Dr. Pereira has also served on the board of directors of Visterra Inc. since July, 2013. Dr. Pereira is a nationally recognized expert on kidney disease and nephrology, is the former Editor of the widely read textbook “Chronic Kidney Disease, Dialysis and Transplantation,” and has over 200 scientific papers to his credit. He currently serves on the board of directors of Africa Healthcare Network, Ltd, a dialysis provider, as the Chairman of the Board, the board of directors of KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), a pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need, the board of directors of Cullinan Pearl Corp, a privately held biotechnology company and a subsidiary of Cullinan Oncology, Inc. (Nasdaq: CGEM), an oncology company. He was the former Executive Chairman of the board of directors of Abeona Therapeutics Inc. (Nasdaq: ABEO), a clinical-stage biopharmaceutical company developing gene and cell therapies for serious diseases. Dr. Pereira is a graduate of St. John’s Medical College, Bangalore, India and has an MBA from the Kellogg Business School, Northwestern University. Dr. Pereira obtained his D.M. in Nephrology and M.D. in Internal Medicine from Post Graduate Institute, Chandigarh, India.
What is Brian Jg Pereira's net worth?
The estimated net worth of Brian Jg Pereira is at least $134.75 thousand as of November 12th, 2025. Pereira owns 54,333 shares of ProKidney stock worth more than $134,746 as of March 11th. This net worth approximation does not reflect any other investments that Pereira may own. Learn More about Brian Jg Pereira's net worth.
How do I contact Brian Jg Pereira?
Has Brian Jg Pereira been buying or selling shares of ProKidney?
Brian Jg Pereira has not been actively trading shares of ProKidney in the last ninety days. Most recently, Brian Jg Pereira sold 502,136 shares of the business's stock in a transaction on Thursday, November 13th. The shares were sold at an average price of $2.37, for a transaction totalling $1,190,062.32. Learn More on Brian Jg Pereira's trading history.
Who are ProKidney's active insiders?
Are insiders buying or selling shares of ProKidney?
In the last year, ProKidney insiders bought shares 4 times. They purchased a total of 1,787,716 shares worth more than $1,175,418.66. In the last year, insiders at the sold shares 3 times. They sold a total of 860,642 shares worth more than $2,196,242.64. The most recent insider tranaction occured on November, 13th when Director Brian Jg Pereira sold 502,136 shares worth more than $1,190,062.32. Insiders at ProKidney own 41.5% of the company.
Learn More about insider trades at ProKidney. Information on this page was last updated on 11/13/2025.
